Teva Pharmaceutical Industries Limited’s (TEVA) stock has risen 72.5% so far this year compared with an increase of 17.9% for the industry. The stock has also outperformed the sector and the S&P 500, as seen in the chart below.TEVA Stock Outperforms Industry, Sector & S&P 500Image Source: Zacks Investment ResearchThe stock has also been consistently trading above 200-day moving averages since mid-November 2023. In fact, Teva’s stock price is showing improvement after years of remaining suppressed.Teva is th ...